iTonic Holdings Ltd.
ITOC
NASDAQ Capital Market0.32
USD
+0.00
- -
iTonic Holdings Ltd.
ITOC
(NASDAQ Capital Market)
Recent
price
0.32
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- iTonic Holdings Ltd, a healthcare technology company, develops and commercializes brachytherapy treatment planning systems (TPS) and related medical devices used for radioactive particle implantation in cancer treatment; it also pursues AI-driven medical device automation and home health solutions through its Beijing Feitian Zhaoye Technology subsidiary. The company operates primarily in China with expanding activities in international markets through partnerships and acquisitions; it leverages its proprietary TPS platforms to determine target volumes, prescribe doses, and optimize dose distribution while protecting organs at risk. Founded in 1998, the company is headquartered in Beijing, China, and operates under the parent structure of iTonic Holdings Ltd (formerly Pheton Holdings Ltd). Core products and services include FTTPS treatment planning software for brachytherapy; related accession systems and hardware interfaces enabling implantation of radioactive sources; AI-enabled device automation solutions for clinical workflows; and home health platform components supporting remote monitoring and patient management. Latest major changes include strategic acquisitions and partnerships expanding footprint into the U.S. home health market through Pheton Holdings’ 51% stake acquisition in iTonic, issuance of new shares and warrants to sellers, and organizational rebranding from Pheton Holdings Ltd to iTonic Holdings Ltd; these changes accompany broader business shifts toward integrated AI-enabled healthcare platforms and international expansion. Industry segments center on Medical Devices, Healthcare Technology, and Cancer Care Solutions, with target markets spanning hospital oncology departments, radiotherapy centers, and increasingly home health providers globally. Subsidiaries include Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian) and related entities managing TPS development, product commercialization, and support services; the company maintains global partnerships and investor relations activities to support growth and governance initiatives.
ITOC Investors Have Opportunity to Join iTonic Holdings Ltd. Fraud Investigation with the Schall Law Firm
ITOC Investors Have Opportunity to Join iTonic Holdings Ltd. Fraud Investigation with the Schall Law Firm
iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Rosen Law Firm Encourages iTonic Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – ITOC
iTonic Holdings (ITOC) Surges Over 84% After Hours— Here's Why It's Trending